Literature DB >> 19573123

Psychometric validation and use of a novel diabetes in-patient treatment satisfaction questionnaire.

M J Sampson1, H Singh, K K Dhatariya, C Jones, E Walden, C Bradley.   

Abstract

AIMS: To develop the first psychometrically validated Diabetes Treatment Satisfaction Questionnaire for in-patients (DTSQ-IP) and examine determinants of in-patient diabetes treatment satisfaction.
METHODS: We studied 366 in-patients with insulin-treated diabetes at a single UK centre. We developed a 19-item DTSQ-IP to assess in-patient diabetes treatment satisfaction, and collected data on in-patient length of stay (LOS) and in-patient care at the same time.
RESULTS: Psychometric analyses including Principal Components Analysis and Cronbach's alpha reliability coefficient showed that a single satisfaction score (excluding two items scored individually) can be computed for the entire DTSQ-IP, indicating very good internal consistency reliability (0.92). The DTSQ-IP detected considerable dissatisfaction with meal choice and timing (13.7% of in-patients would never have chosen similar meals at home), and with in-patient hypoglycaemia (35.3% felt that their blood glucose was too low most of the time). In-patients on surgical wards, women, and those long established on insulin were significantly more dissatisfied, particularly with competence of hospital staff. Patients who administered their own insulin were not significantly less dissatisfied overall, but were so with the choice of meals (P = 0.005). Multiple regression analysis produced a model accounting for 8.2% of variability in DTSQ-IP (r = 0.29; P = 0.0058) and 21.7% of variability in LOS (r = 0.46; P = 0.0001).
CONCLUSIONS: The DTSQ-IP is a novel, psychometrically validated and sensitive tool that adds to the DTSQ portfolio. The DTSQ-IP facilitates efforts to assess and improve treatment satisfaction in in-patients with diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19573123     DOI: 10.1111/j.1464-5491.2009.02754.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  6 in total

1.  Increased length of inpatient stay and poor clinical coding: audit of patients with diabetes.

Authors:  Harriet Daultrey; Catherine Gooday; Ketan Dhatariya
Journal:  JRSM Short Rep       Date:  2011-10-31

2.  The effects of patient and physician characteristics on early outpatient satisfaction with substance dependence care: results of the SUBUSQOL study.

Authors:  Stéphanie Bourion-Bédès; Raymund Schwan; Paolo Di Patrizio; Guillaume Vlamynck; Sarah Viennet; Maxime Schvartz; Anne Gaunard; Alex Bédès; Isabelle Clerc-Urmès; Cédric Baumann
Journal:  Patient Prefer Adherence       Date:  2017-05-08       Impact factor: 2.711

3.  Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients.

Authors:  Rajesh Garg; Brooke Schuman; Shelley Hurwitz; Cheyenne Metzger; Shreya Bhandari
Journal:  BMJ Open Diabetes Res Care       Date:  2017-03-29

4.  Dapagliflozin for prednisone-induced hyperglycaemia in acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Maaike C Gerards; Gerdien E Venema; Kornelis W Patberg; Martijn Kross; Bert Jan Potter van Loon; Ilse M G Hageman; Dominic Snijders; Dees P M Brandjes; Joost B L Hoekstra; Titia M Vriesendorp; Victor E A Gerdes
Journal:  Diabetes Obes Metab       Date:  2018-02-06       Impact factor: 6.577

5.  A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol.

Authors:  F Dunne; C Newman; D Devane; A Smyth; A Alvarez-Iglesias; P Gillespie; M Browne; M O'Donnell
Journal:  Trials       Date:  2022-09-21       Impact factor: 2.728

6.  Prandial insulin dosing using the carbohydrate counting technique in hospitalized patients with type 2 diabetes.

Authors:  Kathleen M Dungan; Colleen Sagrilla; Mahmoud Abdel-Rasoul; Kwame Osei
Journal:  Diabetes Care       Date:  2013-09-23       Impact factor: 19.112

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.